Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice

NCT04241796 is registered in ClinicalTrials.gov with GRAIL, Inc. as lead sponsor.

NCT NCT04241796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04241796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice
Lead sponsor
GRAIL, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2019
Completion date
January 5, 2022
Enrollment
6,662 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cancer